Skip to main content

Final text of TPP reveals a very bad deal for access to drugs in developing countries

Final text of TPP reveals a very bad deal for access to drugs in developing countries

Médecins Sans Frontières (MSF) spokesperson warns the US House of Representatives that the text of the final TPP agreement extends patent protection in ways that will decrease competition, raise prices and limit access.  It will also hamper innovations such as pediatric formulations of essential medicines.   Read MSF's powerful testimony:  

 

 

 

Share